JP2014230629A - Volatile agent container - Google Patents

Abstract

PROBLEM TO BE SOLVED: To provide a volatile agent container which improves emission efficiency of a volatile agent and suppresses complication of the work of packing a volatile agent.SOLUTION: A volatile agent container includes a plate 13 provided with a through hole 12 and two agent storage parts 15a and 15b formed on both sides of the plate 13 and communicating with each other through the through hole 12. In the agent storage parts 15a and 15b, openings 11a and 11b for emission of a volatile agent 4 are formed so as to face the plate 13, respectively. The openings 11a and 11b are sealed with removable sealing materials 3a and 3b, respectively.

Description

  The present invention relates to a volatile drug container, and more particularly, to an improvement of a volatile drug container formed so that two openings for releasing a volatile drug are opposed to each other.

  The fragrance diffuser is an instrument that supplies a scent into the room by diffusing the fragrance held in the air into the air. Liquid and gel-like fragrances are known. However, liquid fragrances have the disadvantage that they may leak out when the fragrance diffuser falls over. Widely used (for example, Patent Document 1).

  Patent Document 1 describes that a volatile drug is heated and poured into a drug container, and then cooled and solidified. The gel-like volatile drug is a liquid when heated, but solidifies upon cooling and becomes a gel. For this reason, a gel-like volatile chemical | medical agent can be filled with the drug container of arbitrary shapes by such a method.

  In this type of drug container, an opening for diverging the volatile drug is formed, and this opening is also used when filling the drug container with the volatile drug. If this opening is enlarged, the divergence efficiency of the volatile drug can be improved. In particular, it is considered desirable to provide a large opening on the opposite surface of the drug container, in addition to being able to remarkably improve the divergence efficiency and widely diffusing indoors. However, when the openings are provided on both surfaces of the drug container, there is a problem that the volatile drug whose volume is reduced is unevenly distributed in the drug container and the divergence efficiency is lowered.

  If it is going to solve such a problem, it is possible to provide a partition plate in a medicine container. That is, the container which consists of the shape which piled up the bottom face of two containers which opened one surface can be considered. If it is such a chemical | medical agent container, a volatile chemical | medical agent will be supported by a partition plate, it will become difficult to be unevenly distributed, and the fall of divergence efficiency can be suppressed. However, in this case, it is necessary to fill each of the two drug containers separated by the partition plate with volatile drugs from different openings, and there is a problem that the volatile drug filling operation becomes complicated. .

JP 2004-196354 A

  This invention is made | formed in view of said situation, and it aims at providing the volatile chemical | medical agent container which improved the divergence efficiency of the volatile chemical | medical agent. In particular, it aims to improve the diffusion efficiency of volatile drugs and to diffuse them widely. Moreover, it aims at suppressing the fall of the divergence efficiency in case the volume of a volatile chemical | medical agent reduces. Furthermore, it aims at improving the divergence efficiency of a volatile chemical | medical agent, without complicating the filling operation | work of a volatile chemical | medical agent.

  The volatile drug container according to the present invention includes a plate in which a through hole is formed, and two drug containers formed on both sides of the plate and communicated with each other by the through hole. An opening for diverging the volatile drug is provided to face the plate, and the opening is configured to be sealed with a removable sealing material.

  In this volatile drug container, an opening is formed in each of the two drug containers partitioned by the plate. For this reason, the volatile chemical | medical agent accommodated in the chemical | medical agent storage part can be efficiently diffused.

  In addition, a through hole is formed in the plate, and the two drug accommodating portions are communicated with each other through the through hole. For this reason, the volatile chemical | medical agent accommodated in a chemical | medical agent accommodating part is integrated through a through-hole, and is supported by a through-hole. Therefore, even if the volume is reduced, the volatile drug does not move in the drug container, and it is possible to suppress a decrease in divergence efficiency due to a decrease in surface area due to uneven distribution.

  Furthermore, if any one of the openings is sealed with a sealing material by forming a through-hole in the plate, the volatile drug is filled from the other opening into either of the two drug containers. be able to. For this reason, it is possible to improve the emission efficiency of the volatile drug without complicating the filling operation of the volatile drug.

  ADVANTAGE OF THE INVENTION According to this invention, the volatile chemical | medical agent container which improved the divergence efficiency of the volatile chemical | medical agent can be provided. In particular, an object of the present invention is to improve divergence efficiency while widely diffusing a volatile drug by providing two opposed openings. In addition, by forming the through hole in the plate, it is possible to suppress a decrease in divergence efficiency when the volume of the volatile drug is reduced. Furthermore, by forming a through hole in the plate and sealing the opening with a sealing material, it is possible to improve the efficiency of volatile drug diffusion without complicating the filling operation of the volatile drug.

It is the external view which showed one structural example of the fragrance | flavor diffuser 100 by Embodiment 1 of this invention. It is the expansion | deployment perspective view which expand | deployed the fragrance | flavor diffuser 100 of FIG. 1 for every component. It is sectional drawing at the time of cut | disconnecting the fragrance | flavor container 1 of FIG. 2 by the AA cutting line. It is sectional drawing which showed one structural example of the fragrance | flavor container 1 before use start. It is sectional drawing which showed one structural example of the fragrance | flavor container 1 after a use start. It is explanatory drawing which showed an example of the manufacturing process of the fragrance | flavor diffuser 100 of FIG. It is the external view which showed one structural example of the fragrance | flavor diffuser 200 by Embodiment 2 of this invention. It is the figure which showed one structural example of the fragrance | flavor container 5. FIG. It is sectional drawing at the time of cut | disconnecting the fragrance | flavor diffuser 200 of FIG. 7 by the BB cutting line.

Embodiment 1 FIG.
1-3 is a figure which showed the example of 1 structure of the fragrance | flavor diffuser 100 by Embodiment 1 of this invention. FIG. 1 is an external view of the fragrance diffuser 100, and FIG. 2 is a developed perspective view in which the fragrance diffuser 100 of FIG. 1 is developed for each part. FIG. 3 is a cross-sectional view of the fragrance container 1 of FIG. 2 taken along the line AA.

  The fragrance diffuser 100 is a divergence device for holding a volatile fragrance and releasing it in the air. Here, although the example of the fragrance | flavor diffuser which diffuses a fragrance | flavor as a volatile chemical | medical agent is demonstrated, this invention is not limited only to such a fragrance | flavor diffuser 100. That is, the present invention can also be applied to a volatile chemical spreader that emits any volatile chemical such as a deodorant, insect repellent, fungicide, and insecticide.

  The fragrance diffuser 100 includes a fragrance container 1, a front plate 2a, and a back plate 2b. The fragrance container 1 is a volatile drug container for containing a fragrance, and has a cylindrical shape, for example, a cylindrical shape, with openings 11a and 11b formed on the front and back surfaces thereof. The front plate 2a and the back plate 2b are decorative covers for improving the appearance, and are made of plate-like bodies that respectively cover the front surface and the back surface of the fragrance container 1.

  The fragrance container 1 includes a disk-shaped plate 13 in which a plurality of through holes 12 are formed, and a frame portion 14 formed along the peripheral edge of the plate 13. The frame portion 14 is a wall portion extending in the front-rear direction so as to be orthogonal to the plate 13, and drug storage portions 15 a and 15 b surrounded by the frame portion 14 are formed on both sides of the plate 13, respectively. That is, the two medicine accommodating portions 15 a and 15 b are partitioned by the plate 13 and communicated through the through hole 12. In addition, the fragrance container 1 has a length in the front-rear direction that is shorter than the width of the plate 13 and has a thin shape with the front surface and the back surface as main surfaces. Openings 11a and 11b to be opened are formed.

  The front plate 2a is provided with a large number of slits 21a, two leg portions 22a, and four engagement protrusions 23a. The slit 21a is a ventilation hole for releasing the fragrance. The leg portion 22a is an upright support means for erecting the fragrance diffuser 100 so that the front surface and the back surface of the fragrance container 1 face in the horizontal direction, and from the semicircular protrusion portion protruding in the radial direction. Become. The engagement protrusion 23a is a columnar member extending rearward, and four engagement protrusions 23a are formed on the peripheral edge of the front plate 2a. Protrusions for engaging with the back plate 2b are formed at the tips of these engaging projections 23a.

  The back plate 2b is configured by a large number of slits 21b, two leg portions 22b, and four engagement protrusions 23b. Since the slit 21b and the leg portion 22b have the same configuration as the slit 21a and the leg portion 22a of the front plate 2a, respectively, the description thereof is omitted. The engagement protrusions 23b are columnar members extending forward, and four engagement protrusions 23b are formed at positions corresponding to the engagement protrusions 23a of the front plate 2a. A concave portion for inserting the convex portion of the engaging protrusion portion 23a is formed at the tip of the engaging protrusion portion 23b.

  The fragrance diffuser 100 fits the protrusions of the engagement protrusions 23a and the recesses of the engagement protrusions 23b so that the fragrance container 1 is sandwiched between the front plate 2a and the back plate 2b. Assembled by.

  4 and 5 are cross-sectional views showing one configuration example of the fragrance container 1 before and after the start of use. FIG. 4 shows the state of the fragrance container 1 before the start of use, and FIG. The state of the fragrance container 1 after the start of use is shown.

  In the fragrance container 1, two medicine accommodating portions 15a and 15b are formed. The medicine accommodating portions 15 a and 15 b are both surrounded by a frame portion 14 and are composed of spaces partitioned from each other by a plate 13. In addition, an opening 11 a facing the main surface of the plate 13 is provided in the medicine container 15 a in front of the plate 13, and a medicine container 15 b behind the plate 13 is opposed to the main surface of the plate 13. An opening 11b is provided. Furthermore, the medicine accommodating portions 15 a and 15 b communicate with each other through the through hole 12.

  A volatile gel fragrance 4 is accommodated in each of the medicine accommodating portions 15a and 15b. The fragrance 4 is also filled in the through-hole 12, and the fragrance in the medicine accommodating portions 15 a and 15 b is integrated through the through-hole 12. As the fragrance 4, for example, a material obtained by dispersing a gelling agent such as carrageenan, locust bean gum or duran gum in water and further adding a fragrance component, a surfactant or the like is used.

  In the fragrance container 1 before the start of use, the fragrance 4 is accommodated in most of the medicine accommodating portions 15a and 15b. Moreover, in order to prevent the fragrance | flavor 4 from volatilizing, the sealing materials 3a and 3b are provided in the opening parts 11a and 11b, respectively. The sealing materials 3a and 3b are means for sealing the openings 11a and 11b in order to seal the medicine accommodating portions 15a and 15b. For example, a sealing cap made of resin, rubber or metal is used. . Moreover, it can replace with a sealing cap and can also use the resin sheet etc. which consist of the aluminum sheet affixed on the peripheral part of opening part 11a, 11b, PE (polyethylene), or PVC (polyvinyl chloride).

  The sealing materials 3a and 3b are configured so that the user can easily remove them, and are removed at the start of use. When the user peels off the sealing materials 3a and 3b, the sealed medicine accommodating portions 15a and 15b communicate with the outside through the openings 11a and 11b, and the fragrance 4 is diffused indoors. be able to. In this fragrance diffuser 100, since the fragrance container 1 has a thin shape and the openings 11a and 11b are formed on both main surfaces thereof, a wide opening area can be secured and high divergence efficiency is realized. can do. Further, since the openings 11a and 11b are both in the horizontal direction and are directed in opposite directions, the scent can be diffused in the entire room.

  After removing the sealing materials 3a and 3b, the fragrance 4 gradually evaporates and its volume decreases. At this time, the fragrance 4 evaporates from the portions close to the openings 11a and 11b, and the portions close to the plate 13 remain. In general, the fragrance 4 having a reduced volume moves in the fragrance container 1 and the surface area is reduced due to the biased position. On the other hand, in the fragrance diffuser 100, the fragrance 4 in the medicine accommodating portions 15a and 15b is held at the center in the fragrance container 1 by the through hole 12 with the plate 13 sandwiched therebetween. That is, it is held so as not to move in the vertical and horizontal directions as well as in the longitudinal direction. For this reason, even if the volume of the fragrance 4 is reduced, the position thereof is not biased, and it is possible to suppress the divergent effect from being lowered.

  FIG. 5 is an explanatory view showing an example of the configuration at the time of manufacturing the fragrance diffuser 100 of FIG. 1, and shows a state when the fragrance container 1 is filled with the fragrance 4. The fragrance 4 is filled into the fragrance container 1 from the nozzle 40 in a heated liquid state.

  In the fragrance container 1, openings 11a and 11b are respectively formed on the front surface and the back surface facing each other. For this reason, after sealing one opening part 11b with a sealing material, the fragrance | flavor 4 is poured from the other opening part 11a. The fragrance 4 poured into the medicine container 15a from the opening 11a also flows into the medicine container 15b through the through-hole 12, and the fragrance 4 is filled in both the medicine containers 15a and 15b. . The fragrance 4 filled in the fragrance container 1 is solidified by natural cooling to become a gel, and the other opening 11a is sealed thereafter.

  Since the volume of the fragrance 4 is reduced by cooling, the medicine container 15a on the other opening 11a side into which the fragrance 4 is poured is filled as compared with the medicine container 15b on the one opening 11b side. The fragrance 4 is slightly reduced.

  In the fragrance diffuser 100 according to the present embodiment, openings 11a and 11b are formed on both opposing main surfaces of the fragrance container 1 having a thin shape. For this reason, a large opening area can be secured and high divergence efficiency can be obtained. Moreover, a fragrance can be spread | diffused widely in the whole room by standing up so that the main surface of the fragrance | flavor agent container 1 may face a horizontal direction.

  Further, the internal space of the fragrance container 1 is partitioned by the plate 13 into two medicine accommodating portions 15a and 15b. Further, the plate 13 is formed with a through-hole 12, and the two medicine accommodating portions 15a and 15b communicate with each other. For this reason, the fragrance | flavor 4 in chemical | medical agent accommodating part 15a, 15b is integrated via the through-hole 12, and is hold | maintained by the through-hole 12 in the state which pinched | interposed the plate 13. FIG. Therefore, even if the volume of the fragrance 4 is reduced, the fragrance 4 is fixedly supported at the center of the fragrance container 1 and is disposed in an uneven manner in the fragrance container 1, thereby reducing the surface area and reducing the divergence efficiency. Can be prevented.

  Furthermore, since the medicine storage portions 15a and 15b are communicated with each other through the through-hole 12, if one opening is sealed and the fragrance 4 is poured from the other opening, both the medicine storage portions 15a and 15b can be filled with a fragrance. That is, it is not necessary to fill the fragrance 4 for each medicine container 15a, 15b, the manufacturing process can be simplified, and an increase in manufacturing cost can be suppressed.

  In addition, in the said embodiment, although the opening parts 11a and 11b demonstrated the example when formed in the whole surface of the front surface and back surface of the fragrance | flavor container 1, this invention is not limited only to such a structure. . Although it is desirable that the openings 11a and 11b have a large area, they may not necessarily be formed on the entire surface and the entire back surface.

  Moreover, although the said embodiment demonstrated the example in case the through-hole 12 was formed in the center of the plate 13, this invention is not limited only to such a structure. The through hole 12 only needs to be able to hold the fragrance having a reduced volume, and may not be formed at the center of the plate 13.

Embodiment 2. FIG.
In the first embodiment, the example of the fragrance diffuser 100 in which the front plate 2a and the back plate 2b are provided on both main surfaces of the fragrance container 1 has been described. On the other hand, this Embodiment demonstrates the example of the fragrance | flavor diffuser 200 with which the fragrance | flavor container was covered with the cover.

  6-8 is the figure which showed the example of 1 structure of the fragrance | flavor diffuser 200 by Embodiment 2 of this invention. FIG. 6 is an external view of the fragrance diffuser 200, and the cover 6 is shown. FIG. 7 is a view showing a state where the cover 6 is removed from the fragrance diffuser 200 of FIG. 6, and the fragrance container 5 is shown. FIG. 8 is a cross-sectional view of the fragrance diffuser 200 of FIG. 6 taken along the line BB.

  The fragrance diffuser 200 is configured by covering the fragrance container 5 with a cover 6. The fragrance container 5 has a thin rectangular shape, and openings 51a and 51b are formed on both main surfaces of the fragrance container 5 so as to open the entire surface. The cover 6 has a thin rectangular shape with an open bottom, and its inner dimension is slightly larger than the outer dimension of the fragrance container 5. In addition, a large number of slits 61 a and 61 b are formed on both main surfaces of the cover 6 and face the openings 51 a and 51 b of the fragrance container 5, respectively.

  The internal space of the fragrance container 5 is divided into two medicine accommodating portions by a plate 53 having a through hole 52 formed in the center. Each medicine container is filled with a volatile gel-like fragrance 4, and these fragrances are integrated through a through hole 52.

  The openings 51a and 51b are sealed with a sealing material to seal the internal space of the fragrance container 5. The filling of the fragrance 4 is performed by pouring the fragrance 4 from the other opening 51a after sealing one opening 51b with a sealing material. For this reason, filling of the fragrance | flavor with respect to two chemical | medical agent storage parts can be performed simultaneously through the same opening part.

1 Air freshener container (volatile chemical container)
2a Front plate 2b Back plate 3a, 3b Sealant 4 Fragrance 5 Fragrance container 6 Cover 11a, 11b Opening portion 12 Through hole 13 Plate 14 Frame portion 15a, 15b Drug accommodating portion 21a, 21b Slit 22a, 22b Leg portion 23a, 23b Engaging protrusions 51a and 51b Opening 52 Through-hole 53 Plates 61a and 61b Slit 100 and 200 Fragrance diffuser

Claims (1)

A plate with through holes formed therein;
Two drug containing portions formed on both sides of the plate and communicated with each other by the through-hole,
The medicine container is provided with an opening for releasing the volatile medicine so as to face the plate, respectively.
The opening is sealed with a removable sealing material, respectively.

Images